Isomorphic Labs Raises $5 Billion for AI Drug Design
By The Defiant

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.
Read it in your languageMachine translation by Google of the publisher's page
Explained in this story
Artificial intelligence
Computer systems that perform tasks that normally require human intelligence, such as understanding language, recognising images or making decisions.
AI is changing work, media and public services, raising questions about jobs, safety and regulation.
More about Artificial intelligenceClinical trial
A research study that tests a medicine, vaccine or treatment on volunteers to find out whether it is safe and works.
Trial results decide whether new treatments are approved for patients.
More about Clinical trialMore in AI
From the blog
Old Glory Bank Embraces XRP and Prepares New Offerings
Old Glory Bank announces plans to incorporate XRP support and launch a custodial wallet by the third quarter of 2027,…
Analyzing the XRP Slump and the Bottom of Crypto Bear Markets
A severe crypto market downturn erased $230 billion in value, sending XRP down 10.92% to $0.95. Despite extreme fear, analysts…
Analyst Egrag Crypto Predicts Massive XRP Price Surge Ahead
Cryptocurrency analyst EGRAG CRYPTO predicts a massive XRP price surge dubbed the face-melting phase, targeting up to $27 based on…









